Human Vasodilatory Effect of GLP-1

Sponsor
Papworth Hospital NHS Foundation Trust (Other)
Overall Status
Completed
CT.gov ID
NCT03502083
Collaborator
(none)
11
15

Study Details

Study Description

Brief Summary

Comprehensive assessment of human vasodilatory effect of GLP-1 in forearm and coronary arteries

Condition or Disease Intervention/Treatment Phase
  • Drug: GLP-1 (7-36)Amide
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
11 participants
Allocation:
Non-Randomized
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Basic Science
Official Title:
Vasodilatory Effect of GLP-1
Actual Study Start Date :
Dec 1, 2015
Actual Primary Completion Date :
Mar 1, 2017
Actual Study Completion Date :
Mar 1, 2017

Outcome Measures

Primary Outcome Measures

  1. Change in IMR (index of microcirculatory resistance) with GLP-1 compared with baseline [Change from baseline]

    Change in coronary microcirculatory resistance from baseline

  2. Forearm bloodflow ratio with GLP-1 [Change from baseline]

    Peripheral vasodilatory response of GLP-1

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Waiting list for elective PCI to LAD Able to give informed consent Over 18
Exclusion Criteria:
  • GLP-1 based therapy Insulin Calcium channel blockers Nicorandil Nitrates

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Papworth Hospital NHS Foundation Trust

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Papworth Hospital NHS Foundation Trust
ClinicalTrials.gov Identifier:
NCT03502083
Other Study ID Numbers:
  • 14/EE/0018
First Posted:
Apr 18, 2018
Last Update Posted:
Apr 18, 2018
Last Verified:
Apr 1, 2018
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 18, 2018